dual PDE 3/4 inhibitors (Scottish Biomedical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual PDE 3/4 inhibitors (Scottish Biomedical)
Drug Alias Namedual phosphodiesterase 3/4 inhibitors (Scottish Biomedical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsPhosphodiesterase 3 inhibitors
TargetsPhosphodieterase 4Phosphodiesterase 3
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSB Drug Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSB Drug Discovery
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A